RHHBY - Roche Holding AG

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in CHF. All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue57,205,00051,789,00050,353,000
Cost of Revenue18,655,00015,920,00015,445,000
Gross Profit38,550,00035,870,00034,908,000
Operating Expenses
Research Development11,587,00011,346,0009,571,000
Selling General and Administrative13,619,00010,680,00011,529,000
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss13,343,00013,843,00013,807,000
Income from Continuing Operations
Total Other Income/Expenses Net86,00036,000-260,000
Earnings Before Interest and Taxes13,429,00013,879,00013,547,000
Interest Expense861,0001,081,0001,572,000
Income Before Tax12,568,00012,798,00011,975,000
Income Tax Expense3,513,0003,221,0002,928,000
Minority Interest2,633,0002,451,0002,319,000
Net Income From Continuing Ops9,056,0009,576,0009,047,000
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income9,056,0009,576,0009,047,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares9,056,0009,576,0009,047,000